Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-γ

Table 1 General data and pathologic diagnosis of hfgl2 positive samples

Diagnosis	Case	Gender		Age (yr)	Subtype	Metastasis
		F	M
Colon carcinoma	21	12	9	58.27 ± 10.27	AC 21	17
Breast cancer	20	0	20	49.70 ± 11.06	IDC 20	16
Lung cancer	20	17	3	55.17 ± 12.53	SCC 5	19
					SqC 5
					AC 7
					AdCa 3
Gastric cancer	26	13	13	55.8 ± 15.88	AC 26	20
Esophageal carcinoma	18	15	3	56.44 ± 8.63	SqC 15	13
					AC 3
Cervix cancer	22	0	22	39.14 ± 6.48	SqC 16	22
					AC 6

AC: Adenocarcinoma; IDC: Infiltrating ductal carcinoma; SCC: Small cell carcinoma; SqC: Squamous carcinoma; AdCa: Adenosquamous carcinoma.

Table 2 Histological localization and involved cell type in hfgl2 positive samples

Tumor type	Case	Hfgl2 positive	Histological localization and cases
			Tumor cell	CD57+	CD3+, CD8+	CD68+	VWF
Colon carcinoma	21	21	19	20	18	21	17
Breast cancer	20	20	18	20	20	20	18
Lung cancer	22	20	18	20	19	20	18
Gastric cancer	26	26	25	26	13	26	25
Esophageal carcinoma	19	18	18	16	15	18	14
Cervix cancer	25	22	20	21	21	22	22